CN113666860B - Preparation method of 7-ethyl tryptol - Google Patents
Preparation method of 7-ethyl tryptol Download PDFInfo
- Publication number
- CN113666860B CN113666860B CN202010411678.4A CN202010411678A CN113666860B CN 113666860 B CN113666860 B CN 113666860B CN 202010411678 A CN202010411678 A CN 202010411678A CN 113666860 B CN113666860 B CN 113666860B
- Authority
- CN
- China
- Prior art keywords
- ethyl
- reaction
- ethylene carbonate
- temperature
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims abstract description 20
- PIIZLMYXLGYWTN-UHFFFAOYSA-N 7-ethyl-1h-indole Chemical compound CCC1=CC=CC2=C1NC=C2 PIIZLMYXLGYWTN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003513 alkali Substances 0.000 claims abstract description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 239000007810 chemical reaction solvent Substances 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 36
- -1 hydroxyethyl group Chemical group 0.000 abstract description 12
- 238000003786 synthesis reaction Methods 0.000 abstract description 11
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 6
- 238000009776 industrial production Methods 0.000 abstract description 5
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 239000001569 carbon dioxide Substances 0.000 abstract description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 22
- 239000000706 filtrate Substances 0.000 description 21
- 230000008569 process Effects 0.000 description 20
- 239000012074 organic phase Substances 0.000 description 18
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000006783 Fischer indole synthesis reaction Methods 0.000 description 5
- 239000012280 lithium aluminium hydride Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- PIAOXUVIBAKVSP-UHFFFAOYSA-N γ-hydroxybutyraldehyde Chemical compound OCCCC=O PIAOXUVIBAKVSP-UHFFFAOYSA-N 0.000 description 5
- MLPVBIWIRCKMJV-UHFFFAOYSA-N 2-ethylaniline Chemical compound CCC1=CC=CC=C1N MLPVBIWIRCKMJV-UHFFFAOYSA-N 0.000 description 4
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 4
- 229960005293 etodolac Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- JLRIEIUOGSMPQS-UHFFFAOYSA-N 3-ethoxyoxolane Chemical compound CCOC1CCOC1 JLRIEIUOGSMPQS-UHFFFAOYSA-N 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 239000006035 Tryptophane Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- HBHPTOKYVGZBAJ-UHFFFAOYSA-N (2-ethylanilino)azanium;chloride Chemical compound Cl.CCC1=CC=CC=C1NN HBHPTOKYVGZBAJ-UHFFFAOYSA-N 0.000 description 1
- JHPOWXCLWLEKBY-UHFFFAOYSA-N (2-ethylphenyl)hydrazine Chemical class CCC1=CC=CC=C1NN JHPOWXCLWLEKBY-UHFFFAOYSA-N 0.000 description 1
- PXWYZLWEKCMTEZ-UHFFFAOYSA-N 1-ethyl-2-nitrobenzene Chemical compound CCC1=CC=CC=C1[N+]([O-])=O PXWYZLWEKCMTEZ-UHFFFAOYSA-N 0.000 description 1
- RESTWAHJFMZUIZ-UHFFFAOYSA-N 1-ethyl-4-nitrobenzene Chemical compound CCC1=CC=C([N+]([O-])=O)C=C1 RESTWAHJFMZUIZ-UHFFFAOYSA-N 0.000 description 1
- BVRLGLJZJOMPBI-UHFFFAOYSA-N 4-[(2-ethylphenyl)hydrazinylidene]butan-1-ol Chemical compound CCc1ccccc1NN=CCCCO BVRLGLJZJOMPBI-UHFFFAOYSA-N 0.000 description 1
- PGSRQDDORRHHFB-UHFFFAOYSA-N 7-ethyl-1,3-dihydroindol-2-one Chemical compound CCC1=CC=CC2=C1NC(=O)C2 PGSRQDDORRHHFB-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 238000006680 Reformatsky reaction Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- JOVOSQBPPZZESK-UHFFFAOYSA-N phenylhydrazine hydrochloride Chemical compound Cl.NNC1=CC=CC=C1 JOVOSQBPPZZESK-UHFFFAOYSA-N 0.000 description 1
- 229940038531 phenylhydrazine hydrochloride Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Abstract
The invention belongs to the technical field of medicine synthesis, and particularly relates to a preparation method of 7-ethyl tryptol, which takes 7-ethyl indole as a raw material to react with ethylene carbonate under the action of alkali to synthesize 7-ethyl tryptol; the method has the advantages that the ethylene carbonate reagent product of the hydroxyethyl group is carbon dioxide, the method is clean and environment-friendly, the post-treatment is convenient, the method avoids the use of dangerous chemical reagents, the reaction is milder, the economy and the environment-friendly are realized, the yield is higher, and the method is suitable for industrial production.
Description
Technical Field
The invention belongs to the technical field of medicine synthesis, and particularly relates to a preparation method of 7-ethyl tryptol.
Background
Etodolac (Etodolac) is a powerful non-steroidal anti-inflammatory analgesic, is used for treating rheumatic arthritis, rheumatoid arthritis, osteoarthritis and other diseases, has the characteristics of good tolerance, light toxic and side effects, strong analgesic effect and the like, has few adverse reactions of gastrointestinal tracts, and is particularly suitable for old patients. The drug was developed by AHP Wyeth-Ayesrt company in the United states and was first marketed in the United kingdom in 1985, and has the following chemical structural formula:
7-ethyl tryptol is used as a key intermediate for synthesizing etodolac, directly influences the production, market supply and quality problems of the medicine, and has the following chemical structural formula:
the preparation methods reported at present for 7-ethyl color alcohol mainly comprise the following steps:
U.S. Pat. No. 5,172,72A 1 and the document "Synthesis of 7-ethyl-1H-indole", jiangsu chemical, 1993,21 (1), 17-19, 7-ethylindole, J.pharmaceutical & Chem., 1997,7 (1), 57-59, heteromycles, 2018,96 (1), 67-73 report that the by-product of the industrial production of p-nitroethylbenzene, namely chloramphenicol, or its downstream intermediate, is used as a raw material, reduced by tin powder/hydrochloric acid to give o-ethylaniline, then cyclized with chloral hydrate and hydroxylamine hydrochloride under acidic conditions to give an oximido acetamide derivative, then cyclized in concentrated sulfuric acid to give 7-ethylindolinone, then reduced with lithium aluminum hydride to give 7-ethylindole, finally reacted with oxalyl chloride, and then reduced by sodium borohydride to give the final product:
however, the process has the advantages of longer synthetic route, inconvenient operation, lower overall yield, higher risk of the used reducing agent and high price, and is not suitable for industrial production.
U.S. Pat. No.3,124A and literature "study of etodolac Synthesis Process" Tianjin chemical industry, 2004,18 (5), 22-23, edolac Synthesis Process "chemical theory, 2005,56 (8), 1536-1540 similarly uses o-nitroethylbenzene as raw material, and O-ethylaniline is obtained by reduction with iron powder, then diazotization reaction, reduction with sodium sulfite (sodium bisulfite or stannous chloride) to obtain o-ethylphenylhydrazine hydrochloride, and reflux reaction with 2, 3-dihydrofuran in 1, 4-dioxane to obtain the product:
the Fischer Indole synthesis method is a main flow process for producing 7-ethyl color alcohol at present, and is the synthesis method with the simplest process and the lowest production cost at present. The Fischer Indole synthesis appears to be a cleaner synthesis from the equation alone, but this is not actually the case for the synthesis of 7-ethyl tryptol, a technique which, on the one hand, requires the use of large amounts of non-environmentally or expensive organic solvents such as acetonitrile, DMF, DMAc, isobutanol, etc., and low solvent recovery; on the other hand, the Fischer rearrangement reaction needs strong acid catalysis to form indole ring, but the strong acid can also catalyze the indole ring to generate purple black sticky polymer through chain reaction, so that a plurality of impurities are generated, the crude product is low in purity, the post-treatment is complex, and the 7-ethyl color alcohol obtained through reaction separation is a dark (generally brownish black) sticky jelly or oily substance. The separation and purification method of this low-purity dark jelly is reported to be a silica gel column separation method (see U.S. Pat. No.3,124 and WO 9959970), an extraction separation method (see W02005002523), and the like. Although silica gel column chromatography can obtain 7-ethylchromanol as a high-purity product, the use of a large amount of solvent is uneconomical and impractical in industrial production. Although the extraction separation method is an effective method for improving the purity of industrial 7-ethyl color alcohol at present, the purity of the crude 7-ethyl color alcohol (the content is generally 60-85%) is still only 95-97% after separation and purification, and the color of the product is dark brown (see W02005002523) and still unsatisfactory.
In addition, as the system contains unreacted aldehyde (obtained by hydrolyzing 2, 3-dihydrofuran) and 2, 3-dihydrofuran after the indole is cyclized, the following three byproducts are easily generated, so that the crude product has low purity and complex post-treatment:
in addition, 2, 3-dihydrofuran with higher price is used in the process, so that the production cost is correspondingly increased.
Chinese patent application CN1740153A, CN1740154A and literature 7-New technology for synthesizing ethyl color alcohol, university chemical engineering report 2010,24 (1), 127-131 are prepared by hydrolyzing 2, 3-dihydrofuran under acidic condition to obtain 4-hydroxybutanal, reacting with o-ethyl phenylhydrazine salt to generate 4-hydroxybutanal o-ethyl phenylhydrazone, and finally Fischer cyclizing under concentrated sulfuric acid or glycol ether solvent, and vacuum distilling or recrystallizing with cyclohexane to obtain the target product:
however, the above process still has difficulty avoiding the drawbacks of the Fischer industry synthesis and the use of the more expensive 2, 3-dihydrofuran.
Similarly, chinese patent application CN107522649A and Chemical Engineering & processing: process Intensification,121 (2017) 144-148 adopt a tubular continuous flow reaction technology of microwave heating to react phenylhydrazine hydrochloride with 4-hydroxybutanal, thereby realizing continuous synthesis reaction of 7-ethylchromanol. Although the use of strong acids in the Fischer Indole synthesis is theoretically avoided, the process is of limited batch size and is not suitable for commercial scale-up.
Literature Heteroycles, 2003,60 (5) 1095-1110 uses 3-ethoxytetrahydrofuran, an active precursor of 2, 3-dihydrofuran, as a donor for 4-hydroxybutyraldehyde, which also inevitably results in higher production costs:
journal of Labelled Compounds and Radiopharmaceuticals, vol.XIV, no.3,1978,411-425, modified the strategy, was prepared by hydrolysis reduction after introduction of cyano group to 3-substituted-7 ethylindole:
however, the process uses the highly toxic KCN, has high operation risk, and the obtained cyano-substituted intermediate has 2-isomer impurities, so that the purity of the obtained product is low, and in addition, the carboxylic acid is reduced by using lithium aluminum hydride with high price and high risk, so that the operation safety is low, and the industrial large-scale production is difficult.
Furthermore, documents Journal of Medicinal Chemistry,1976,19 (3), 391-395 have designed and synthesized related indolinone derivatives using the Reformatsky reaction, but the process also requires the use of expensive and dangerous lithium aluminum hydride:
in addition, document Organic Syntheses, coll.vol.9, p.417 (1998); vol.74, p.248 (1997) first uses tert-butyldimethylchlorosilane (TMDMSCl) to protect 1-position indoline under the condition of n-butyllithium, then introduces bromine at 3-position through NBS, further carries out Li substitution under the condition of n-butyllithium, and then carries out nucleophilic substitution with propylene oxide, and deprotection to obtain related derivatives:
however, the process has the advantages of more synthesis steps, more complicated operation and lower overall yield; meanwhile, the method needs to be applied to the dangerous reagent n-butyl lithium which is in contact with water and carbon dioxide for spontaneous combustion, is heated, is inflammable by open flame and needs ultralow-temperature operation for multiple times, so that the operation safety is low, and the industrial large-scale production is difficult.
In summary, the preparation method of 7-ethyl-primary-color alcohol has the following problems:
1. the process route is longer, the final product relates to decompression fractionation operation, and the operation is complicated, so that the overall yield is lower.
2. The method adopts the Fischer Indole synthesis method under the strong acid condition to prepare the target product, and the obtained product has more impurities, is difficult to purify and has lower yield.
3. The process needs to use a large amount of acetonitrile, DMF, DMAc, isobutanol and other solvents which are not environment-friendly or expensive, and the recovery rate of the solvents is low.
4. The process adopts lithium aluminum hydride with higher risk and the highly toxic KCN, so that the operation safety is lower.
5.2, 3-dihydrofuran or 3-ethoxytetrahydrofuran which is an active precursor of 2, 3-dihydrofuran with a relatively high price is adopted as a donor of 4-hydroxybutyraldehyde, so that the problem of high production cost is caused.
In summary, the existing preparation method of 7-ethyl tryptophane has many defects in the aspects of safe process, complicated operation, low yield, higher production cost and the like, so that the research and the search of a reaction route which is mild in reaction condition, simple and convenient in operation process, high in product yield and purity and low in production cost and is suitable for industrialized production of 7-ethyl tryptophane still need to be solved.
Disclosure of Invention
Aiming at the problems of the existing 7-ethyl color alcohol preparation technology, the invention provides a novel preparation method of 7-ethyl color alcohol. The method has mild reaction conditions and simple operation process, and the prepared target product has higher purity and yield.
The specific technical scheme of the invention is as follows:
the preparation method of the 7-ethyl color alcohol specifically comprises the following steps:
and (3) adding 7-ethylindole and alkali into a reaction solvent at room temperature, adding ethylene carbonate at a controlled temperature, and after the addition, controlling the temperature until the reaction is finished, and performing post-treatment to obtain a target product.
Preferably, the alkali is selected from one or a combination of potassium carbonate, sodium bicarbonate, triethylamine, N, N-diisopropylethylamine and pyridine; among them, potassium carbonate is particularly preferred.
Preferably, the reaction solvent is one or a combination of benzene, toluene, xylene, N-dimethylformamide, 1, 4-dioxane, dimethyl sulfoxide and N-methylpyrrolidone, wherein N, N-dimethylformamide is particularly preferred.
In a preferred scheme, the feeding mole ratio of the 7-ethylindole to the alkali to the ethylene carbonate is 1:1.0 to 2.0:1.5 to 3.0, preferably 1:1.2:2.2.
preferably, the temperature of the ethylene carbonate is controlled to be 0-30 ℃; the reaction temperature is 90-120 ℃.
Preferably, the post-treatment steps are as follows: cooling the reaction solution to room temperature, filtering, adding methylene dichloride into the filtrate to extract and separate an organic phase, washing the organic phase by saturated saline water, drying by anhydrous sodium sulfate, filtering, and concentrating the filtrate under reduced pressure until the filtrate is dried to obtain the target product.
The invention has the beneficial effects that:
1. the invention provides a new preparation method of 7-ethyl primary color alcohol, which is prepared by taking 7-ethyl Indole as a starting material and ethylene carbonate under an alkaline condition, so that the problems of high production cost and more impurities, difficult purification and low yield of a product obtained by preparing a target product through a Fischer Indole synthesis method due to the adoption of 2, 3-dihydrofuran or an active precursor 3-ethoxytetrahydrofuran thereof as a donor of 4-hydroxy butyraldehyde are avoided;
2. meanwhile, the use of lithium aluminum hydride and the highly toxic KCN with higher risk is effectively avoided, the operation safety is improved, the target product does not need to be subjected to decompression fractionation operation and purification, and the production operation is simplified;
3. the ethylene carbonate reagent product with the hydroxyethyl group is carbon dioxide, so that the method is clean and environment-friendly and is convenient for post-treatment;
4. compared with the prior art, the preparation process of the 7-ethyl primary alcohol shortens the process route, is simple and convenient to operate and safe, and is more suitable for industrial production.
Detailed Description
The invention is further illustrated by the following examples, with the understanding that: the examples of the present invention are intended to be illustrative of the invention and not to be limiting of the invention, so that simple modifications to the invention which are based on the method of the invention are within the scope of the invention as claimed.
The structure of the 7-ethylchromanol compound obtained by the invention is confirmed as follows:
ESI-HRMS(m/z):190.1234[M+H] + ; 1 H NMR(400MHz,CDCl 3 )δ8.05(br s,1H),7.50(d,J=8.0Hz,1H),7.15-7.07(m,3H),3.92(t,J=6.5Hz,2H),3.05(t,J=6.0Hz,2H),2.87(q,J 1 =8.0Hz,J 2 =15.5Hz,J 3 =23.0Hz,2H),1.38(t,J=7.8Hz,3H); 13 C NMR(100MHz,CDCl 3 )δ136.05,127.83,126.16,122.02,119.94,119.30,116.06,112.40,62.34,29.58,24.40,13.63.
in the following examples, various processes and methods, which are not described in detail, are conventional methods well known in the art.
Example 1
7-ethylindole (14.52 g,0.1 mol), potassium carbonate (16.58 g,0.12 mol) and N, N-dimethylformamide (150 ml) are added at the room temperature, ethylene carbonate (19.37 g,0.22 mol) is added at the temperature of 10-15 ℃, after the addition is finished, the temperature is controlled at 110-115 ℃ until the reaction is finished, the reaction solution is cooled to room temperature and filtered, methylene dichloride (100 ml) is added into the filtrate, an organic phase is taken out after the separation, the organic phase is washed by saturated saline (100 ml multiplied by 2), dried by anhydrous sodium sulfate and filtered, the filtrate is concentrated to dryness under reduced pressure, and the target product is obtained, the yield is 98.7%, and the HPLC purity is 99.92%.
Example 2
7-ethylindole (14.52 g,0.1 mol), potassium carbonate (13.82 g,0.1 mol) and ethylene carbonate (19.37 g,0.22 mol) are added into 1.4-dioxane (150 ml) at the temperature of 0-5 ℃, ethylene carbonate (19.37 g,0.22 mol) is added after the addition, the temperature is controlled to 90-100 ℃ until the reaction is finished, the reaction solution is cooled to room temperature and filtered, methylene dichloride (100 ml) is added into the filtrate, an organic phase is separated, the organic phase is washed by saturated saline (100 ml multiplied by 2), dried by anhydrous sodium sulfate, filtered and the filtrate is concentrated to dryness under reduced pressure, thus obtaining the target product, the yield is 94.6%, and the HPLC purity is 99.86%.
Example 3
7-ethylindole (14.52 g,0.1 mol), potassium carbonate (27.64 g,0.2 mol) and ethylene carbonate (19.37 g,0.22 mol) are added into dimethylbenzene (150 ml) at the temperature of 25-30 ℃, after the addition, the temperature is controlled to 115-120 ℃ until the reaction is finished, the reaction solution is cooled to room temperature and filtered, dichloromethane (100 ml) is added into filtrate, an organic phase is taken out from the filtrate, the organic phase is washed by saturated saline (100 ml multiplied by 2), anhydrous sodium sulfate is dried and filtered, the filtrate is concentrated to dryness under reduced pressure, and the target product is obtained, the yield is 93.9%, and the HPLC purity is 99.76%.
Example 4
7-ethylindole (14.52 g,0.1 mol), potassium carbonate (34.56 g,0.25 mol) and ethylene carbonate (19.37 g,0.22 mol) are added into toluene (150 ml) at the temperature of-5-0 ℃, after the addition, the temperature is controlled to be 85-90 ℃ until the reaction is finished, the reaction solution is cooled to room temperature and filtered, methylene dichloride (100 ml) is added into filtrate, an organic phase is taken out from the filtrate, the organic phase is washed by saturated saline (100 ml multiplied by 2), anhydrous sodium sulfate is dried and filtered, the filtrate is concentrated to dryness under reduced pressure, and the target product is obtained, the yield is 86.9%, and the HPLC purity is 99.65%.
Example 5
7-ethylindole (14.52 g,0.1 mol), sodium bicarbonate (10.08 g,0.12 mol) and paraxylene (150 ml) are added at room temperature, ethylene carbonate (13.21 g,0.15 mol) is added at the temperature of 10-15 ℃, after the addition is finished, the temperature is controlled at 110-115 ℃ until the reaction is finished, the reaction solution is cooled to room temperature and filtered, dichloromethane (100 ml) is added into the filtrate, an organic phase is separated, the organic phase is washed by saturated saline (100 ml multiplied by 2), anhydrous sodium sulfate is dried and filtered, the filtrate is concentrated to dryness under reduced pressure, and the target product is obtained, and the yield is 95.5% and the HPLC purity is 99.88%.
Example 6
7-ethylindole (14.52 g,0.1 mol), triethylamine (12.14 g,0.12 mol) and dimethyl sulfoxide (150 ml) are added at room temperature, ethylene carbonate (26.42 g,0.3 mol) is added at the temperature of 10-15 ℃, after the addition is finished, the temperature is controlled at 110-115 ℃ until the reaction is finished, the reaction solution is cooled to room temperature, the filtration is carried out, dichloromethane (100 ml) is added into the filtrate, an organic phase is taken out by separating the solution, the organic phase is washed by saturated saline (100 ml multiplied by 2), anhydrous sodium sulfate is dried, the filtration is carried out, the filtrate is concentrated to dryness under reduced pressure, and the target product is obtained, the yield is 93.7%, and the HPLC purity is 99.78%.
Example 7
7-ethylindole (14.52 g,0.1 mol), N-diisopropylethylamine (15.51 g,0.12 mol) and N-methylpyrrolidone (150 ml) are added at room temperature, ethylene carbonate (8.81 g,0.1 mol) is added at a temperature of 10-15 ℃, after the addition is completed, the temperature is controlled at 110-115 ℃ until the reaction is finished, the reaction solution is cooled to room temperature and filtered, dichloromethane (100 ml) is added into the filtrate, an organic phase is separated, the organic phase is washed by saturated saline (100 ml multiplied by 2), dried by anhydrous sodium sulfate, filtered, and the filtrate is concentrated to dryness under reduced pressure, thus obtaining the target product with 86.6 percent of yield and 99.66 percent of HPLC purity.
Example 8
7-ethylindole (14.52 g,0.1 mol), pyridine (9.50 g,0.12 mol) are added into N-methylpyrrolidone (150 ml), ethylene carbonate (30.82 g,0.35 mol) is added at the temperature of 10-15 ℃, after the addition is finished, the temperature is controlled at 120-125 ℃, the reaction solution is cooled to room temperature and filtered, methylene dichloride (100 ml) is added into the filtrate, an organic phase is taken out through separation, the organic phase is washed by saturated saline (100 ml multiplied by 2), anhydrous sodium sulfate is dried and filtered, the filtrate is concentrated to be dry under reduced pressure, and the target product is obtained, the yield is 85.2%, and the HPLC purity is 99.64%.
Claims (2)
1. The preparation method of 7-ethyl color alcohol is characterized in that 7-ethyl indole reacts with ethylene carbonate under the action of alkali to obtain 7-ethyl color alcohol, and the preparation method comprises the following steps: adding 7-ethylindole and alkali into a reaction solvent at room temperature, adding ethylene carbonate at a controlled temperature, and after the addition, controlling the temperature until the reaction is finished, and performing post-treatment to obtain a target product, wherein the synthetic route is as follows:
the alkali is selected from potassium carbonate, sodium bicarbonate and triethylamine,N,N-one or a combination of diisopropylethylamine, pyridine;
the reaction solvent is benzene, toluene, xylene,N,N-dimethylformamide, 1, 4-dioxane, dimethyl sulfoxide,N-one of methyl pyrrolidone or a combination thereof;
the temperature of the added ethylene carbonate is 0-30 ℃;
the reaction temperature is 90-120 ℃.
2. The preparation method according to claim 1, wherein the feeding molar ratio of the 7-ethylindole to the alkali to the ethylene carbonate is 1:1.0 to 2.0:1.5 to 3.0.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010411678.4A CN113666860B (en) | 2020-05-14 | 2020-05-14 | Preparation method of 7-ethyl tryptol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010411678.4A CN113666860B (en) | 2020-05-14 | 2020-05-14 | Preparation method of 7-ethyl tryptol |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113666860A CN113666860A (en) | 2021-11-19 |
CN113666860B true CN113666860B (en) | 2024-03-15 |
Family
ID=78537551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010411678.4A Active CN113666860B (en) | 2020-05-14 | 2020-05-14 | Preparation method of 7-ethyl tryptol |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113666860B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115650898A (en) * | 2022-09-13 | 2023-01-31 | 华南理工大学 | Synthesis method of 2-substituted 7-methoxy-tryptophol derivative |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1740153A (en) * | 2005-08-23 | 2006-03-01 | 杭州科本化工有限公司 | Prepn process of 7-ethyl tryptophol |
CN1740154A (en) * | 2005-08-23 | 2006-03-01 | 杭州科本化工有限公司 | Prepn process of 7-ethyl tryptophol |
CN105829288A (en) * | 2013-12-19 | 2016-08-03 | 埃科特莱茵药品有限公司 | Antibacterial 1h-indazole and 1h-indole derivatives |
CN107522649A (en) * | 2017-08-08 | 2017-12-29 | 衢州学院 | A kind of 7 ethyl tryptophol method for continuously synthesizing of microwave assisted |
KR20190081250A (en) * | 2017-12-29 | 2019-07-09 | 아크로마코리아 주식회사 | The preparing method of disperse orange dye |
-
2020
- 2020-05-14 CN CN202010411678.4A patent/CN113666860B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1740153A (en) * | 2005-08-23 | 2006-03-01 | 杭州科本化工有限公司 | Prepn process of 7-ethyl tryptophol |
CN1740154A (en) * | 2005-08-23 | 2006-03-01 | 杭州科本化工有限公司 | Prepn process of 7-ethyl tryptophol |
CN105829288A (en) * | 2013-12-19 | 2016-08-03 | 埃科特莱茵药品有限公司 | Antibacterial 1h-indazole and 1h-indole derivatives |
CN107522649A (en) * | 2017-08-08 | 2017-12-29 | 衢州学院 | A kind of 7 ethyl tryptophol method for continuously synthesizing of microwave assisted |
KR20190081250A (en) * | 2017-12-29 | 2019-07-09 | 아크로마코리아 주식회사 | The preparing method of disperse orange dye |
Non-Patent Citations (4)
Title |
---|
7-乙基色醇的合成新工艺;吕延文,等;《高校化学工程学报》;第24卷(第1期);127-131 * |
A versatile synthetic methodology for the synthesis of tryptophols;Simon J. Garden,等;《Tetrahedron》;第58卷;8399-8412 * |
Hydroxyalkylation of indole with cyclic carbonates catalyzed by ionic liquids;GAO Guohua,等;《Chinese Journal of Catalysis》;第34卷(第6期);1187-1191 * |
Paul M Wood,等.Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4- {[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino] methyl} phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.《ChemMedChem》.2010,第5卷(第9期),1577-1593. * |
Also Published As
Publication number | Publication date |
---|---|
CN113666860A (en) | 2021-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102627573B (en) | Synthesis method for 5-aminolevulinic acid hydrochloride | |
WO2017096996A1 (en) | Preparation method for cobimetinib | |
CN114634441B (en) | Method for synthesizing 6, 6-dimethyl-3-azabicyclo [3,1,0] hexane | |
CN113666860B (en) | Preparation method of 7-ethyl tryptol | |
CN110790721B (en) | Synthetic method of ceftazidime side chain ethyl ester | |
CN110305018B (en) | Preparation method of 3-bromo-2-fluoronitrobenzene | |
CN105968040B (en) | A kind of preparation method of Lei Dipawei intermediate | |
WO2016161826A1 (en) | Method for preparing 4-isopropylamino-1-butanol | |
CN110684000B (en) | Process for preparing benzofuran derivatives | |
CN112645833A (en) | Synthesis method of (S) -2, 6-diamino-5-oxohexanoic acid | |
CN112225647A (en) | Method for synthesizing 5-bromo-2-methoxyphenol | |
CN108101934B (en) | Process for the preparation of trabectedin and intermediates thereof | |
CN112194548B (en) | Alpha-amino-gamma-butyrolactone compound and preparation method thereof | |
CN111574463B (en) | Rivastigmine intermediate compound IV | |
CN114437007A (en) | Preparation method of prucalopride intermediate | |
CN113929612B (en) | Preparation method of etodolac intermediate | |
CN111499528A (en) | Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate by using terbutaline sulfate intermediate | |
CN108203396B (en) | Synthesis of enkephalinase inhibitor | |
KR101856566B1 (en) | New preparation method of 4'-Hydroxy-4-biphenylcarboxylic acid | |
CN114085161B (en) | Intermediate for preparing 5-ALA-HCl and preparation method of 5-ALA-HCl | |
CN115504923A (en) | Preparation method of 7-ethyl tryptophol | |
CN111171094B (en) | Vanillin intermediate and preparation method and application thereof | |
CN115232054A (en) | 7-ethyl tryptophol intermediate compound | |
CN114656401A (en) | Method for preparing 4-chloropyridine-2-methyl formate serving as sorafenib key intermediate and suitable for industrial production | |
CN108503583B (en) | Alkylation method of nitrogen-hydrogen-containing compound and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |